Women’s Health Leaders On Challenges And Opportunities, Post-Election
Post-election, leaders from Cadence OTC, Evvy, Flora Fertility, G2G Consulting, and Winx Health share their summary of and ...
FiercePharma9d
FDA proposes ban on main ingredient in many OTC decongestants
Common oral medicines that have been used for decades as decongestants such as Sudafed, NyQuil and Benadryl may soon be ...
Medpage Today on MSN10d
FDA Plans to Ban Popular Cold Med
The FDA announced on Thursday a proposed order to remove oral phenylephrine as an active ingredient in over-the-counter (OTC) ...
FDA moves to pull popular decongestant from shelves amid effectiveness concerns
The FDA announced a proposal to remove oral phenylephrine – a common ingredient in many popular over-the-counter ...
A Popular Decongestant Doesn’t Work. The FDA Is Finally Doing Something About It
Oral phenylephrine was shown to be ineffective for treating nasal congestion over a year go. This week, the FDA took the ...
FDA seeks to remove ingredient from cold medicines after data shows it does not work
The U.S. Food and Drug Administration is taking the first step to remove an ingredient in non-prescription cold medicines ...
7 Best Invisible Hearing Aids In 2024 - An Audiologist's Guide
The Soundly team spends hundreds of hours per month researching and reviewing hearing aids. These are the best invisible ...
ABC79d
FDA moves to pull nasal decongestant in some cold medicines from shelves amid effectiveness concerns
The US Food and Drug Administration announced a proposal to remove oral phenylephrine - a common ingredient in many popular ...
Yahoo10d
The FDA wants to ban a common ingredient in over-the-counter cold and allergy medications
director of the Office of Nonprescription Drug Products in CDER. “Consumers can also talk to their doctor or pharmacist about ...
Channel 30009d
FDA moves to pull popular decongestant from shelves amid effectiveness concerns
it will allow manufacturers time to “either reformulate or remove drug products containing oral phenylephrine from the market,” Dr. Theresa Michele, director of the FDA’s Office of ...
REISSUE: African Business Professional Arnold "Kojo" Asante to Join Methes' Management Team
('Methes' - (OTC PINK:MEIL) is pleased to announce that they have retained Mr. Arnold 'Kojo' Asante to the Methes' Management Team, servicing the responsibilities as the company's International ...